Nanoform Finland Oyj (NANOFH.HE)
EUR 1.29
(2.7%)
EUR 1.29
(2.7%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.26 EUR | 10.34% |
| 2022 | -0.29 EUR | 0.0% |
| 2021 | -0.29 EUR | 17.14% |
| 2020 | -0.35 EUR | -75.0% |
| 2019 | -0.20 EUR | -298.41% |
| 2018 | -0.05 EUR | -298.41% |
| 2017 | -0.01 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.09 EUR | -32.16% |
| 2024 Q2 | -0.06 EUR | 31.89% |
| 2023 Q3 | -0.05 EUR | 39.4% |
| 2023 Q1 | -0.06 EUR | 19.41% |
| 2023 Q4 | -0.07 EUR | -29.47% |
| 2023 FY | - EUR | 10.34% |
| 2023 Q2 | -0.09 EUR | -51.48% |
| 2022 Q3 | -0.07 EUR | 12.5% |
| 2022 FY | - EUR | 0.0% |
| 2022 Q4 | -0.07 EUR | -1.57% |
| 2022 Q2 | -0.08 EUR | -14.29% |
| 2022 Q1 | -0.07 EUR | 8.74% |
| 2021 Q1 | -0.06 EUR | -5.45% |
| 2021 Q3 | -0.06 EUR | 11.14% |
| 2021 Q4 | -0.08 EUR | -23.31% |
| 2021 Q2 | -0.07 EUR | -16.67% |
| 2021 FY | - EUR | 17.14% |
| 2020 FY | - EUR | -75.0% |
| 2020 Q4 | -0.06 EUR | 5.17% |
| 2020 Q3 | -0.06 EUR | 57.14% |
| 2020 Q2 | -0.14 EUR | -94.44% |
| 2020 Q1 | -0.07 EUR | -20.6% |
| 2019 Q1 | -0.03 EUR | 0.0% |
| 2019 Q4 | -0.06 EUR | -19.4% |
| 2019 FY | - EUR | -298.41% |
| 2019 Q3 | -0.05 EUR | -31.93% |
| 2019 Q2 | -0.04 EUR | -43.56% |
| 2018 FY | - EUR | -298.41% |
| 2017 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Biohit Oyj | 0.12 EUR | 316.667% |
| Herantis Pharma Oyj | 0.02 EUR | 1695.092% |